Interpretation -The choice of graft fi xation infl uences the risk of revision after primary ACLR with hamstring tendon autograft.
■
The most commonly used grafts in Scandinavia for anterior cruciate ligament reconstruction (ACLR) are hamstring tendon autografts (HT) or patellar tendon autografts (Granan et al. 2009 ). There are multiple devices available on the market for fi xation of the graft. Most devices have been evaluated mechanically tested with acceptable results (Ahmad et al. 2004 , Milano et al. 2006 , Aga et al. 2013 . Numerous clinical studies have found similar objective or subjective outcomes comparing different fi xation techniques (Laxdal et al. 2006 , Rose et al. 2006 , Moisala et al. 2008 , Myers et al. 2008 , Harilainen and Sandelin 2009 , Drogset et al. 2011 , Frosch et al. 2012 , Gifstad et al. 2014 . Hence, there is no defi nite recommendation for the best fi xation technique and the surgeon's choice of fi xation is likely to be infl uenced by personal experience, local traditions, and possibly marketing from the industry.
A recent study (Persson et al. 2015) from the Norwegian Knee Ligament Registry (NKLR) identifi ed combinations of fi xations for HT with increased risk of revision at 2 years. In addition, a higher risk of revision when using cortical buttons compared with transfemoral or intratunnel fi xations in the femur was observed. These fi ndings call into question the increasing use of cortical buttons for HT fi xation (Ahlden et al. 2012 ). In addition, Andernord et al. (2014) found a reduced risk of early revision when a metal interference screw was used to fi xate semitendinosus grafts in the tibia.
This study further investigates the risk of revision for the most common fi xation techniques and devices in HT reconstructions during the period 2004-2011, using a combined dataset from all 3 Scandinavian ACL registries (the NKLR, the Swedish National Anterior Cruciate Ligament Registry, and the Danish Knee Ligament Reconstruction Register).
Materials and methods

Data sources
The Scandinavian knee ligament registries were established in [2004] [2005] and are similar in design (Granan et al. 2008 , Ahlden et al. 2012 , Rahr-Wagner and Lind 2016 . Patient-specifi c data (sex, age, previous surgery/injuries to index or contralateral knee), surgical details (graft choice, fi xation choice, potential treatment of other ligament injuries or meniscal/cartilage injuries) and intraoperative fi ndings (meniscal and cartilage injuries and signs of arthrosis) are reported at the time of surgery. Patients are followed prospectively with revision ACLR, subsequent surgery to the index knee, and patient-reported outcome (Knee Injury and Osteoarthritis Outcome Score at 1, 2, 5, and 10 years follow-up) as endpoints. The report rates to the registries are similar, from 86% to ≥ 90% (Ytterstad et al. 2012 , Rahr-Wagner et al. 2013a , www.aclregister.nu 2014 .
This study includes all 38,666 patients registered from the start of the Scandinavian registries up to December 31, 2011, with a primary ACLR with an HT. The following data were considered in the study: date of primary and potential revision reconstruction, patient age and sex, fi xation of the graft in femur and tibia, activity at primary injury, location (right/left knee), meniscal injury or treatment (yes/no), cartilage injury (yes/no), medial collateral injury (yes/no), and other concomitant injuries (fractures, nerve injuries, and vascular injuries). Patients with concomitant ligament injuries treated surgically were not included.
Exposure
We analyzed the revision rate and risk dependent on what tibial and femoral fi xation device was used in the primary ALCR. The fi xation device in the femur and tibia was either registered by the catalogue number of each device by using the unique bar-code sticker delivered by the manufacturer, or reported manually by the surgeon with either the registered trademark name of the device or a description of the fi xation design, such as interference screw. Devices used in fewer than 500 patients were grouped according to their design and point of graft fi xation. The femoral devices in the dataset were grouped as: cortical fi xation (Endobutton [Smith & Nephew] 
Statistics
Statistical analyses were performed using SPSS Statistics software version 22 (SPSS Inc, IBM Corp, Armonk, NY, USA). All tests were 2-sided with a 0.05 signifi cance level.
Unadjusted cumulative implant revision curves were established using Kaplan-Meier estimates and crude 2-and 5-year revision percentages are reported. Unadjusted and adjusted hazard ratios (HR) with 95% confi dence intervals (CI) were estimated in Cox regression analyses. The multivariable analyses were stratifi ed for country. The assumption of proportional hazards of the Cox regression model was evaluated with log-log plot and was found suitable. All survival analyses were performed with revision as the endpoint. No data were received on death or emigration. Patients were at risk and followed until revision or end of study.
Confounding factors
Patient age (5-year categories) at the time of the primary reconstruction, sex, meniscal injury to 1 or both menisci (yes/ no), cartilage injury (yes/no), and activity at primary injury (pivoting activity [soccer, team handball, alpine activities]/ other activities) were considered as possible confounding factors as these are potential risk factors for revision and may also infl uence the choice of fi xation method. Further, none of the factors were considered as possible mediating variables. Additional analyses showed that meniscal injury and cartilage injury was not associated with, and thus did not inform, the fi xation method. They were therefore not entered into the multivariable Cox regression analysis. Additional adjustment was made for corresponding fi xation in the tibia when analyzing femoral fi xations and for corresponding fi xation in the femur when analyzing tibial fi xations.
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Results
The mean age at surgery was 28 years, and 57% were men. The median time from initial injury to the time of primary ACLR was 8 months (range 0-45 years). The most commonly used fi xations in the femur were the Endobutton and Rigidfi x, used in 14,106 and 12,041 patients respectively. The most commonly used tibial fi xations were interference screw and Intrafi x, used in 18,640 and 13,014 patients respectively. The median overall follow-up time was 2.8 (1.8-4.3) years (Table 1 ). The most commonly used combinations of fi xations (femoral x tibial) were Rigidfi x x Intrafi x and Endobutton x Interference screw, used in 8,023 and 8,006 patients respectively ( Table 2) .
The use of femoral fi xation with Endobutton increased during the entire study period while the usage of Rigidfi Revision rate during the fi rst postoperative year was low (Figures 3 and 4) .
The 5-year revision rate according to femoral fi xation was 5.0% (CI 4.4-5.7) for Endobutton, 3.4% (CI 3.0-3.8) for Rigidfi x, and 3.5% (CI 2.8-4.1) for Transfi x. For tibial fi xation the 5-year revision rate was 4.2% (CI 3.7-4.6) for interference screw, 4.0% (CI 3.0-3.8) for Intrafi x, and 2.5% (CI 1.4-3.7) for Rigidfi x (Figures 3, 4 and Table 3 ).
In the multivariable analysis, the HR for revision was 0.7 for the Rigidfi x (CI 0.6-0.8) and Transfi x (CI 0.6-0.9) groups compared with the Endobutton group and 1.9 (CI 1.3-2.9) for the group with the tibial fi xation retro interference screw compared with the interference screw group (Table 4) .
Discussion
In this large multiregistry-based study from the Scandinavian countries, the main fi nding was that the HR for revision was reduced by 30% when using transfemoral fi xation with Rigidfi x or Transfi x compared with cortical fi xation with Endobutton, independent of the tibial fi xation used. The hamstring tendon autograft was fi xed with the cortical fi xation Endobutton in one-third of the patients, with increasing use during the last years of the study period. These results are in line with the recent fi ndings of increased risk of revision within 2 years for cortical fi xation compared with transfemoral fi xation from the NKLR (Persson et al 2015) . One can question the clinical relevance of a minor difference in revision risk. However, when clinical outcome after revision ACLR may be worse than after primary ACLR (Battaglia et al. 2007 , Grassi et al. 2016 , we believe the differences are of interest.
Previously, a variety of outcomes have been studied in clinical studies comparing different fi xation devices and techniques (Drogset et al. 2005 , Rose et al. 2006 , Capuano et al. 2008 , Moisala et al. 2008 ) with similar outcomes in the examined 2) Retro interference screw 1.8 (1.2-2.6) 1.9 (1.3-2.9) Rigidfi x 0.6 (0.3-0.9) 0.9 (0.5-1.4) Other/ unknown 1.1 (0.7-1.6) 1.0 (0.6-1.5) a Adjusted analysis model stratifi ed for country (Sweden, Denmark, Norway) and adjusted for gender, age at surgery (5-year categories), activity at primary injury, and corresponding fi xation in tibia or femur.
groups. However, there are a few clinical, biomechanical, and anatomical studies that have reported differences between different graft fi xations in the femur. A recent meta-analysis by Browning et al. (2017) included 41 clinical level 1-4 studies comparing clinical outcome for patients treated with an ACLR with 4-strand hamstring autograft using either suspensory or aperture fi xation. They found better arthrometric stability and fewer graft ruptures using suspensory compared with aperture fi xation at a minimum of 2-year follow-up; however, they included graft fi xation in the femur with cross-pins in the suspensory group. In a clinical trial of double-bundle ACLR, Ibrahim et al. (2015) found that 4 out of 32 patients with ACL grafts that were fi xed in the femur with cortical fi xation had > 5 mm of postoperatively instrumented knee laxity compared with 0 out of 34 patients with transfemoral fi xation at a mean follow-up of 2.5 years. They found no difference between the 2 groups in the Lachman and pivot-shift test. Frosch et al. (2012) compared, in a prospective non-randomized study, femoral fi xation with bioabsorbable interference screws in 31 cases and bioabsorbable Rigidfi x in 28 cases. They found similar subjective results but less side-to-side anterior translation as measured with a KT-1000 arthrometer in the cases with femoral fi xation using Rigidfi x. Biomechanical studies most frequently investigate graftfi xation complex stiffness, pull-out strength, or graft-fi xation complex lengthening after cyclic loading. Laxity of the graftfi xation complex and graft-tunnel motion might disturb the biologic incorporation of the graft in the bone tunnel (Hoher et al. 1998 ), leading to a weaker reconstruction. In a cadaver model measuring graft-fi xation complex stiffness in double-looped semitendinosus grafts, To et al. (1999) found the stiffness of the graft and fi xation complex to be dependent on the fi xation method rather than the graft, with decreased stiffness when using a suture loop and a cortical button. Höher et al. (1998) found up to 3 mm of graft-tunnel motion when using a titanium button and polyester tape to fi x quadruple hamstring grafts within the femoral bone tunnel. To further investigate the histological insertion point or the graft itself there is a need for more studies where samples are collected from revision ACLRs.
There has been a debate as to whether the surgical technique for femoral tunnel drilling affects the clinical outcome. Both Rigidfi x and Transfi x are likely to mainly have been fi xed through a transtibial technique (TT) for drilling the femoral tunnel. TT has been shown to have a lower risk of revision compared with the anteromedial (AM) technique in a previous register study (Rahr-Wagner et al. 2013b ). The authors argued that it could be due to the increased load on an anatomic reconstructed graft, due to potential problems with a shorter femoral tunnel or as a result of the surgeon's learning curve when the new AM technique was introduced. However, they did not adjust for graft fi xation in their analysis. Liu et al. (2015) found, in a systematic review, superior results for the AM technique based on physical examination, and it is possible that the mentioned difference in revision risk could be due to an unknown confounder, such as the graft fi xation.
A change from transfemoral devices to cortical fi xation has previously been reported from the Swedish ACL registry, probably as a result of the focus on anatomic ACL reconstruction using the AM technique (Ahlden et al. 2012 ). This tendency is also clear in our study.
Among the investigated tibial fi xation devices the retro interference screw was the only device with a statistically significantly higher risk of revision compared with the interference screw. The retro interference screw (available in titanium or degradable poly-L-lactic acid [PLLA] ) is placed retrogradely into the tibial bone tunnel from inside the joint. Although poor results have been reported in a previous biomechanical study (Scannell et al. 2015) , and the possible risk of failure when using PLLA screws (Drogset et al. 2005 , Persson et al. 2015 could explain the increased revision risk for the retro interference screw found in this study, we interpret the results with caution due to the small sample size. Further, we did not have data defi ning the material of the included retro interference screws and thus may not know whether this could have contributed to the inferior results.
A limited number of register studies have been conducted on the current topic. Andernord et al. (2014) found a statistically signifi cant lower incidence of revision surgery when a metal interference screw was used in semitendinosus tendon autograft reconstructions compared with a bioabsorbable interference screw, AO screw, metal interference screw + staple, or Intrafi x registered in the Swedish National Anterior Cruciate Ligament Registry 2005-2011. This was, however, not found in the group with a combined semitendinosus and gracilis graft, which was used in four-fi fths of the patients, in line with our results.
Strengths and weaknesses
The most important strength in this study is the large sample size of the groups investigated. A randomized controlled trial is diffi cult to conduct with enough statistical power to investigate a rare endpoint such as revision ACLR (Naylor and Guyatt 1996) . A sample size calculation shows that 1,000 patients are needed in each group to detect a statistically signifi cant difference in 2-year revision rates of 2.4% and 4.7%, equivalent to a hazard rate ratio of 2 (with a 2-sided 0.05 level and power of 80%). In general, prospective registry-based cohort studies are considered to be hypothesis-generating and not proving causality. However, in modern observational studies where potential biases are considered, estimates of treatment effects may be similar to those found in randomized controlled trials (Benson and Hartz 2000) . Therefore, we believe our study to have a good methodology to investigate the risk of failure for different surgical techniques, such as choice of fi xation method for the graft.
The baseline data of the Norwegian registry have been shown to be congruent with other registries (Maletis et al. 2011 . Accordingly, we believe the results to be applicable not only to the countries where the study was conducted, but to a general orthopedic community.
We acknowledge the existing weaknesses of this study. For the smallest patient groups our results might be infl uenced by hospital-dependent revision rates. Experienced surgeons at large-volume clinics might be more prone to revise patients, and could have a different fi xation choice for the primary ALCR than surgeons in low-volume clinics. These surgeons could also attract more high-level athletes with a higher risk of re-injury. We have no complete data on the surgeons' experience, the postoperative rehabilitation protocol, graft size, activity level of the patient, if TT or AM technique was used for femoral drilling, or if the hamstring tendons are semitendinosus grafts or a combination of semitendinosus and gracilis, which are factors that potentially could infl uence the risk of revision.
The use of revision surgery as the endpoint is a robust outcome measure, but it does not include patients with subjective or objective graft failures that have not undergone revision surgery. Although the number of graft failures is probably greater than the number of patients reaching our endpoint, we believe the observed differences are valid. In addition, we have no reason to believe that patients in certain fi xation groups would be more prone to seek clinical attention and be considered for revision surgery. We do not have the data on why the patients were revised, which could potentially differ between fi xation groups.
We have no data on death or emigration, which potentially could bias our results as a competing risk to revision. With a mean age of 28 years in the population, occurrence of death in the follow-up is likely to be low. We do not believe that occurrence of emigration would differ between the groups. Further, we do not have data on possible bilateral observations included. Even though the occurrence is probably not different amongst the groups investigated, this might have biased our results.
Summary
Although that the cause of revision ACLR is often multifactorial, the results from this study suggest that there could be substantial differences in revision risk dependent on what fi xation method is used in hamstring autograft ACL reconstructions.The results illustrate the need for continuous multiregister cooperation with fi xation devices registered by catalogue number to allow for early detection of possible implant failures.
